Molecular screening for 22Q11. 2 deletion syndrome in patients with congenital heart disease

J Huber, VC Peres, AL de Castro, TJ dos Santos… - Pediatric …, 2014 - Springer
Few studies have investigated the prevalence of 22q11. 2 deletion syndrome (22q11. 2DS)
among patients with isolated heart defects or nonconotruncal heart defects. Polymerase …
被引用次数：25 相关文章

Molecular Screening for 22Q11. 2 Deletion Syndrome in Patients With Congenital Heart Disease

J Huber, VC Peres, AL Castro, TJ Santos, LF Beltrão… - Pediatric …, 2014 - infona.pl
Few studies have investigated the prevalence of 22q11. 2 deletion syndrome (22q11. 2DS)
among patients with isolated heart defects or nonconotruncal heart defects. Polymerase …

Molecular screening for 22Q11. 2 deletion syndrome in patients with congenital heart disease.

J Huber, VC Peres, AL de Castro… - Pediatric …, 2014 - europepmc.org
Few studies have investigated the prevalence of 22q11. 2 deletion syndrome (22q11. 2DS)
among patients with isolated heart defects or nonconotruncal heart defects. Polymerase …

Molecular Screening for 22Q11. 2 Deletion Syndrome in Patients With Congenital Heart Disease.

J Huber, V Peres, A Castro, T Santos… - Pediatric …, 2014 - search.ebscohost.com
Few studies have investigated the prevalence of 22q11. 2 deletion syndrome (22q11. 2DS)
among patients with isolated heart defects or nonconotruncal heart defects. Polymerase …
[PDF] academia.edu

[PDF][PDF] Molecular Screening for 22Q11. 2 Deletion Syndrome in Patients With Congenital Heart Disease

J Huber, VC Peres, AL de Castro, TJ dos Santos… - academia.edu
Few studies have investigated the prevalence of 22q11. 2 deletion syndrome (22q11. 2DS)
among patients with isolated heart defects or nonconotruncal heart defects. Polymerase …
[PDF] diretoriacientificaicfuc.org.br

[PDF][PDF] Molecular Screening for 22Q11. 2 Deletion Syndrome in Patients With Congenital Heart Disease

J Huber, VC Peres, AL de Castro, TJ dos Santos… - diretoriacientificaicfuc.org.br
Few studies have investigated the prevalence of 22q11. 2 deletion syndrome (22q11. 2DS)
among patients with isolated heart defects or nonconotruncal heart defects. Polymerase …

Molecular screening for 22Q11. 2 deletion syndrome in patients with congenital heart disease

J Huber, VC Peres, AL de Castro… - Pediatric …, 2014 - pubmed.ncbi.nlm.nih.gov
Few studies have investigated the prevalence of 22q11. 2 deletion syndrome (22q11. 2DS)
among patients with isolated heart defects or nonconotruncal heart defects. Polymerase …
[PDF] academia.edu

[PDF][PDF] Molecular Screening for 22Q11. 2 Deletion Syndrome in Patients With Congenital Heart Disease

J Huber, VC Peres, AL de Castro, TJ dos Santos… - academia.edu
Few studies have investigated the prevalence of 22q11. 2 deletion syndrome (22q11. 2DS)
among patients with isolated heart defects or nonconotruncal heart defects. Polymerase …